Keros Therapeutics (KROS) Revenue (2019 - 2026)
Keros Therapeutics (KROS) posted Revenue of $385,000 for Q4 2025, down 87.3% from $3.04 million a year earlier and down 97.3% from the prior quarter.
Powered by 
Analysis
Keros Therapeutics (KROS) Revenue (2019 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics' Revenue came in at $244.06 million.
- Annual Revenue shows a four-year compound annual growth rate of 86.7% (FY2021 to FY2025).
- In prior years, Keros Therapeutics' Revenue was $3.55 million in FY2024, $151,000 in FY2023 and $20.1 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Revenue since Q2 2024.
- According to Business Quant data, Revenue for the three prior quarters was $14.26 million (Q3 2025), $18.17 million (Q2 2025) and $211.25 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 40.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 40.01 Mn |
| Mar 31, 2026 | 367,000.00 |
| Dec 31, 2025 | 385,000.00 |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 18.17 Mn |
| Mar 31, 2025 | 211.25 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 83,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 20.00 Mn |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2019 | 2.50 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 2.50 Mn |
| Mar 31, 2019 | 2.50 Mn |
API Access
Keros Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();